Try our beta test site
39 studies found for:    Open Studies | "Potassium"
Show Display Options
Rank Status Study
21 Recruiting A Clinical Trial to Study the Effects of Two Home Made Mouthwashes in Patients With Gum Diseases
Conditions: Gingivitis;   Periodontitis
Interventions: Procedure: HOT SALT WATER;   Procedure: POTASSIUM PERMANGANATE;   Procedure: CHLORHEXIDINE
22 Recruiting KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients
Condition: BPH (Benign Prostatic Hyperplasia)
Interventions: Procedure: KTP laser;   Procedure: TUR-P
23 Recruiting IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
Condition: Autoimmune Epilepsy
Interventions: Drug: Intravenous Immunoglobulin;   Drug: Placebo/Normal Saline
24 Recruiting Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: SHP626;   Drug: Placebo
25 Recruiting Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl
Condition: Hypokalemia
Interventions: Other: KCl plus 0.9%NaCl;   Other: KCl plus 0.45%NaCl
26 Not yet recruiting A Multicenter Study to Evaluate the Nutritional Suitability of Renastart
Conditions: Chronic Kidney Disease;   Hyperkalemia
Intervention: Dietary Supplement: Renastart
27 Recruiting TOnicity of Perioperative Maintenance SoluTions
Conditions: Thoracic Diseases;   Water-Electrolyte Imbalance;   Fluid Overload;   Fluid Retention;   Sodium Disorder;   Potassium Disorders;   Chloride Disorder
Interventions: Drug: NaCl 0.9% in Glucose 5% + 40mmol/L Potassium;   Drug: Glucion 5%
28 Recruiting Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Hypertension
Interventions: Drug: Spironolactone;   Drug: Placebo
29 Recruiting Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults
Condition: Obesity
Intervention: Drug: amoxicillin and clavulanic acid
30 Recruiting Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39);   Other: placebo
31 Not yet recruiting Intravenous Fluids in Hospitalised Children
Conditions: Hypokalemia;   Hyponatremia;   Hypernatremia;   Dehydration
Interventions: Drug: Plasmalyte Glucos 50 mg/mL;   Drug: 0.45% saline in 5% dextrose
32 Not yet recruiting Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
Condition: Hyperkalemia
Intervention: Drug: Patiromer
33 Not yet recruiting The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma
Condition: Asthma
Intervention: Drug: Budesonide
34 Not yet recruiting An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients (RalAge)
Condition: HIV
Intervention: Other: Observational retrospective cohort to describe RAL data
35 Recruiting Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
Conditions: Glomerulonephritis;   Proteinuria
Interventions: Drug: Shenyankangfu tablets;   Drug: Losartan potassium 50mg;   Drug: Shenyankangfu tablets and Losartan potassium 50mg;   Drug: Shenyankangfu tablets and Losartan potassium 100mg;   Drug: Losartan potassium 100mg
36 Recruiting Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
Conditions: Hyperkalemia;   Resistant Hypertension
Interventions: Drug: Patiromer;   Drug: Placebo;   Drug: Spironolactone
37 Recruiting Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2)
Conditions: Diastolic Heart Failure;   Hypertensive Heart Disease
Interventions: Behavioral: DASH/sodium-restricted diet (DASH/SRD);   Behavioral: Control Diet
38 Recruiting N-of-1 Trials for Blood Pressure Medications in Adults
Conditions: Hypertension;   High Blood Pressure
Interventions: Drug: Losartan;   Drug: Amlodipine;   Drug: Hydrochlorothiazide
39 Recruiting The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Ambrisentan plus Spironolactone;   Drug: Ambrisentan plus Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Study has passed its completion date and status has not been verified in more than two years.